Journal: American Journal of Translational Research
Article Title: EGFR/EGFRvIII partly regulates the tumourigenesis of glioblastoma through the SOX9-GLUT3 axis
doi:
Figure Lengend Snippet: EGFR/EGFRvIII upregulated GLUT3 expression in glioblastoma. (A and B) EGFR and GLUT3 were substantially overexpressed in U87-EGFRvIII and LN229-EGFRvIII cells at the mRNA (A) and protein (B) levels compared with those in wild-type U87 and LN229 cells. (C) Through treatment of U87-EGFRvIII cells with osimertinib and NSC228115, we found that EGFR promoted the expression of GLUT3. Mean ± SD. ***P<0.001. P values were calculated using two-tailed Student’s t-tests and one-way ANOVA.
Article Snippet: Additionally, after adding the EGFR agonist NSC228115 (HY-101084; MedChemExpress, 0.36 μM for 24 h) to U87-EGFRvIII cells, the expression of GLUT3 increased substantially, and after adding the EGFR inhibitor osimertinib (AZD-9291; MedChemExpress, 1 nM for 24 h) to U87-EGFRvIII cells, the expression of GLUT3 decreased substantially ( ).
Techniques: Expressing, Two Tailed Test